跳至主要内容
临床试验/JPRN-UMIN000032055
JPRN-UMIN000032055已完成未知

tudy on Biomarkers Using Circulating Tumor Cells When Administering Osimertinib in Patients with EGFR Mutation-positive Lung Cancer - CTC-BIOME

Toho University0 个研究点目标入组 50 人开始时间: 2018年4月2日最近更新:

试验速览

阶段
未知
状态
已完成
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
ot applicable 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1) Patients with complications or a history of serious lung disorder 2) Patients with intermediate or serious liver disorder 3) Patients with complications or a history of serious QT prolongation (QTc value longer than 500msec, symptom of serious arrhythmia) 4) Pregnant women, women who may possibly be pregnant, women who hope to be pregnant, lactating women and men who declined contraception 5) Patients positive for human immunodeficiency virus (HIV) 6) Patients positive for HBs antigen or hepatitis C virus (HCV RNA) 7) Other patients considered as

研究者

相似试验